- Home
- FGMC vs ANIX Comparison
FGMC vs ANIX Comparison
Compare FGMC & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGMC
- ANIX
- Stock Information
- Founded
- FGMC 2023
- ANIX 1982
- Country
- FGMC United States
- ANIX United States
- Employees
- FGMC N/A
- ANIX N/A
- Industry
- FGMC
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- FGMC
- ANIX Health Care
- Exchange
- FGMC NYSE
- ANIX Nasdaq
- Market Cap
- FGMC 98.9M
- ANIX 84.7M
- IPO Year
- FGMC 2025
- ANIX 1987
- Fundamental
- Price
- FGMC $9.61
- ANIX $2.76
- Analyst Decision
- FGMC
- ANIX Strong Buy
- Analyst Count
- FGMC 0
- ANIX 3
- Target Price
- FGMC N/A
- ANIX $9.00
- AVG Volume (30 Days)
- FGMC 40.9K
- ANIX 50.0K
- Earning Date
- FGMC 01-01-0001
- ANIX 06-03-2025
- Dividend Yield
- FGMC N/A
- ANIX N/A
- EPS Growth
- FGMC N/A
- ANIX N/A
- EPS
- FGMC N/A
- ANIX N/A
- Revenue
- FGMC N/A
- ANIX N/A
- Revenue This Year
- FGMC N/A
- ANIX N/A
- Revenue Next Year
- FGMC N/A
- ANIX N/A
- P/E Ratio
- FGMC N/A
- ANIX N/A
- Revenue Growth
- FGMC N/A
- ANIX N/A
- 52 Week Low
- FGMC $4.48
- ANIX $2.07
- 52 Week High
- FGMC $9.85
- ANIX $4.20
- Technical
- Relative Strength Index (RSI)
- FGMC N/A
- ANIX 49.73
- Support Level
- FGMC N/A
- ANIX $2.60
- Resistance Level
- FGMC N/A
- ANIX $2.87
- Average True Range (ATR)
- FGMC 0.00
- ANIX 0.19
- MACD
- FGMC 0.00
- ANIX 0.02
- Stochastic Oscillator
- FGMC 0.00
- ANIX 78.18
About FGMC FG MERGER II CORP
FG Merger II Corp is a blank check company, incorporated for the purpose of merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities (Business Combination).
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.